AI|ffinity Pipeline

AI|ffinity, in collaboration with external partners, is advancing PROTAC-based therapies by designing novel molecules targeting oncogenic variants of the androgen receptor. This project is part of our oncology-focused pipeline, with active efforts toward licensing and commercialization partnerships.

Target discovery

Hit discovery

Lead generation

Lead optimization

Androgen receptor

Epigenetic targets